The human body beyond Earth

AstroCare is an app for real-time monitoring of vital signs and tracking of medical tests in space, with an AI assistant the crew can ask directly. It is built on research into how long missions on the International Space Station affect the body (blood, bone, radiation, vision and sleep), using NASA data and published studies.

Measure

Blood samples, bone scans, eye examinations, radiation dosimeters and sleep monitoring help researchers track changes over time.

Understand

Results are interpreted against each astronaut’s pre-flight baseline, with attention to individual variation and small sample sizes.

Prepare

Findings guide countermeasures and medical planning for longer missions beyond low Earth orbit.

The Study

Five areas of astronaut health, examined through the methods, findings and conclusions of human spaceflight research.

Blood

Blood research in orbit investigates how microgravity changes circulating blood volume, red blood cell mass and the balance between red-cell destruction and production. These measurements help explain the early “space anaemia” response and why it may persist during a long mission.

10–15%Typical early reduction in red blood cell mass reported in spaceflight studies
+54%Red-cell destruction measured during a six-month ISS study
~167 daysApproximate mission duration in the MARROW astronaut study

How it was studied

Researchers collected blood before, during and after flight and assessed haematological measures, including red-cell mass, haemoglobin-related indicators, reticulocytes and markers associated with red-cell breakdown. The MARROW investigation combined blood sampling with other measurements of bone-marrow and blood-cell function. Comparing these results across mission phases helped distinguish the initial fluid shift from continuing changes in red-cell turnover.

Results and analysis

Earlier flight studies described a rapid decrease in red-cell mass, commonly around 10–15%, during the first days of weightlessness. NASA’s summary of the MARROW findings reports that the astronauts studied destroyed about three million red blood cells per second in space, compared with about two million per second on Earth. The increased destruction continued beyond the initial fluid redistribution, so the phenomenon cannot be explained solely as a short-lived adjustment.

Conclusions

Spaceflight changes red-cell regulation, with an early reduction in red-cell mass and increased destruction that can continue throughout a long mission. Blood monitoring is therefore important not only at launch and landing but also during flight. The exact clinical consequences and the best nutritional or medical countermeasures still require further study.

Bone

In microgravity, weight-bearing bones no longer experience the mechanical loading they receive on Earth. Bone formation and resorption become unbalanced, reducing density and, in some cases, the structural strength of the hip and spine.

1–1.5%Average monthly density loss in weight-bearing bones during long missions
~6 monthsTypical ISS mission duration represented in the principal evidence
~1 yearApproximate time reported for lumbar density recovery in a small follow-up group

How it was studied

NASA and partner teams compare pre-flight and post-flight bone scans, principally using dual-energy X-ray absorptiometry (DXA), with quantitative CT used in some studies to examine bone structure and strength. Blood and urine markers of bone turnover, including resorption markers, provide additional information about how quickly bone tissue is being broken down. Exercise countermeasures such as the Advanced Resistive Exercise Device (ARED), and in some studies bisphosphonate medication, are assessed against these outcomes.

Results and analysis

The supplied report and NASA’s risk summary place average loss in weight-bearing bone at roughly 1–1.5% per month during four-to-six-month missions. The rate varies by skeletal region and by astronaut. ARED reduces losses but does not eliminate them in every study. The supplied report also describes better hip protection when resistance exercise was combined with alendronate, although the treatment group was small.

The regional values in the first chart are not interchangeable: they come from different measurement methods and cohorts. NASA’s broad summary remains approximately 1–1.5% per month in weight-bearing bones.

Conclusions

Bone loss is a cumulative risk of long-duration missions. Exercise is essential and reduces deconditioning, but it does not fully prevent skeletal changes. Monitoring density and turnover, maintaining adequate nutrition and evaluating combined countermeasures are central to protecting astronauts during exploration missions.

Radiation

Outside Earth’s protective atmosphere and much of its magnetic shielding, astronauts are exposed to galactic cosmic rays, trapped particles and occasional solar particle events. Radiation studies quantify exposure so that mission planners can manage cumulative risk.

0.2–0.5 mSvPer day: typical ISS effective-dose range cited in the supplied report
~40–90 mSvEstimated total for a typical six-month ISS mission
600 mSvNASA career effective-dose limit in the cited NASA-STD-3001 requirement

How it was studied

Radiation is monitored using passive dosimeters and, more recently, personal active dosimeters that record exposure over time. Area monitors aboard the ISS measure the radiation environment at different locations. The Space Radiation Analysis Group uses these measurements to estimate crew exposure and support operational decisions. Readings depend on orbital altitude, solar activity, shielding, location inside the station and the type of detector.

Results and analysis

The supplied report gives a typical ISS effective-dose rate of 0.2–0.5 mSv per day and an estimated 40–90 mSv over six months. NASA’s radiation material also describes approximately 0.5 mSv per day as a representative ISS value. The career limit is 600 mSv under the cited current NASA standard.

The charts below also include Mars cruise and Mars surface values taken from RAD/Curiosity measurements. These are estimates for missions beyond low Earth orbit, not outcomes observed in astronauts, and exposure there is highly variable.

Conclusions

Radiation is a cumulative mission constraint rather than a symptom that can be assessed from a single clinical test. Continuous or repeated dosimetry, shielding strategies and solar-event monitoring are essential. A six-month ISS dose is well below the 600 mSv career limit, but deep-space missions may involve a more challenging radiation environment.

Optical

Long-duration spaceflight can alter the structure of the eye and the visual system. NASA groups several of these findings under Spaceflight Associated Neuro-ocular Syndrome (SANS), which is associated with fluid shifts toward the head but is not yet fully understood.

~70%ISS astronauts reported by NASA to experience some swelling at the back of the eye
+0.75 DHyperopic refractive shift used as one clinical indicator in SANS assessment
OCTImaging method used to examine retinal and optic-nerve structures

How it was studied

Eye health is assessed before, during and after flight using visual-acuity and refraction tests, fundus photographs, optical coherence tomography (OCT), ocular ultrasound and tonometry. OCT allows researchers to measure retinal layers and optic-disc changes, while ultrasound can help assess the shape of the globe and surrounding structures. These measurements are compared with the astronaut’s pre-flight baseline and followed after return to Earth.

Results and analysis

NASA describes optic-disc swelling, chorioretinal folds, flattening of the back of the eye and hyperopic shifts among the observed findings. Its current public risk material estimates that around 70% of ISS astronauts experience some swelling at the back of the eye. The frequency and severity vary between individuals, and the mechanisms and long-term consequences remain active research questions. NASA also notes that the clinical significance of intraocular-pressure changes is still uncertain.

Conclusions

Ocular monitoring is a key part of long-duration astronaut health surveillance. The combination of imaging and functional tests is more informative than relying on visual acuity alone. SANS is common enough to warrant routine assessment, but individual outcomes differ and the underlying mechanisms are not fully resolved.

Sleep

Sleep research examines how mission schedules, workload, light exposure and the unusual 90-minute day-night cycle in low Earth orbit affect sleep duration and circadian timing. Sleep is relevant to alertness, decision-making and operational performance.

~6.1 hAverage sleep per night in the ISS cohort in Barger et al. (2014)
8.5 hSleep opportunity scheduled by NASA
24%ISS nights with at least seven hours of sleep in the Barger dataset

How it was studied

Researchers used wrist-worn actigraphy, sleep logs and questionnaires to estimate sleep duration and timing before, during and after missions. In the Barger et al. observational study, sleep was assessed across 80 Shuttle missions and 13 ISS missions, with thousands of nights of ground and in-flight data. These methods make it possible to compare sleep across mission phases and identify the effects of schedule changes and operational demands.

Results and analysis

The supplied report and NASA’s sleep technical brief describe average in-flight sleep of roughly six hours per night. In the ISS group of Barger et al., the mean was 6.09 hours, compared with 6.41 hours in the pre-flight reference interval and 6.95 hours in the first week after return. NASA notes that astronauts commonly experience circadian misalignment and that noise, temperature, discomfort and mission conditions can disrupt sleep.

Conclusions

Sleep restriction is a well-documented operational concern in spaceflight, although it is not inevitable: schedules and sleep environments can make a meaningful difference. Protecting adequate sleep opportunity, managing light and shift changes, and monitoring fatigue are important countermeasures for long missions.

Selected NASA references

The following NASA material was used to check the interpretation and numerical context of the studies above.

Chart sources. Alfrey et al. and NASA NTRS (plasma volume and red-cell mass); Trudel et al., Nature Medicine, 2022; UCSF/Baylor and Keyak et al. (hip strength); Sibonga et al., Bone, 2019; meta-analysis PMC7200725; Mader et al., Ophthalmology, 2011; NASA NTRS SANS 2023; Costantino et al.; Zeitlin et al. and RAD/Hassler; Barger et al., Lancet Neurology, 2014; Mars-500, PLOS ONE, 2014.

How to read the charts. Almost no study measures these parameters every day: the usual data are measurements before and after flight, or at a few points. The lines are therefore schematic, joining published values. Large dots are measured values; dashed lines are interpolations or hypotheses. Green is Earth or reference, blue is flight data, orange is a schematic or hypothesis, and red is a threshold or limit.

Application

AstroCare is a real-time monitoring and medical-test tracking app for astronauts, built on the research in this study.

Monitoring in orbit

The app is designed to show an astronaut’s vital signs as they happen and to keep track of the medical tests planned during a mission. The measurements chosen come from the areas covered in the study.

Live signsHeart rate and daily radiation are always shown. Blood oxygen, respiration, blood pressure, temperature, sleep, exercise minutes and glucose can be added or removed from the Monitor screen.
Medical testsSchedule of blood samples, bone scans, eye examinations and sleep records, plus a dated history of every result (chemistry, coagulation, vitamins, hormones, hydration, muscle and bone density, body mass, eye pressure, hyperopia, radiation, infections) in the Data tab.
RadiationDaily and cumulative dose over the mission.
BaselineComparison with each astronaut’s own pre-flight values, as in the study.
AssistantAn AI assistant the crew can write to in a chat tab on the phone, or speak to by voice on the Apple Watch.
DevicesA full version for the phone and a simplified view for the Apple Watch, with the key signs at a glance.
Preview. The screen shown is a mock-up with illustrative data. The values are not real measurements. You can try it: use the bottom tabs, choose which signs to monitor with “Customize” on Monitor, open the dated test records in Data, complete a test or dismiss an alert. On the watch, tap the microphone.
12:485G  ▮▮▮
Astronaut 03 · ISS · Day 94
LIVE
Heart rate68 bpm
Radiation today0.52 mSvMission total 46 mSv
Scheduled tests
Medical tests
Data
Alerts
AstroCare AssistantAI assistant
Hello, I’m the AstroCare assistant. You can ask me about your vital signs, your scheduled tests or your mission data.
Monitor
Tests
Data
Alerts
Assistant
Phone app
AstroCare12:48
68bpm
SpO₂ 98%Resp 15
Apple Watch · simplified, with voice assistant

The AstroBand

A light, screen-free wristband that keeps measuring when the crew is not looking at a display. It streams its readings to the AstroCare app over Bluetooth Low Energy, so the phone and watch views stay up to date throughout the mission.

Size42 × 16 × 8 mm
Strap130–200 mm, adjustable
WeightUnder 15 g
BatteryMore than 7 days
ResistanceIP68
ConnectivityBluetooth Low Energy
AstroBand wristband, grey silicone strap with a glowing logo on the face
The wristband
Technical drawing of the band: 42 mm long, 16 mm wide, 8 mm thick, strap 130 to 200 mm, under 15 g, over 7 days battery, IP68, Bluetooth Low Energy
Technical specifications
Astronaut on a space station using a tablet while wearing the AstroCare band
In use on board

About Us

A research-led project focused on the human dimension of space exploration.

The study

AstroCare is an app for real-time monitoring of vital signs and tracking of medical tests in space. The study is the research and data collection behind it: it gathers published findings on astronaut health during long-duration spaceflight and organises them into five areas: blood, bone, radiation, vision and sleep. For each one it explains how the data were collected, what was observed and what conclusions can be drawn. Measured observations, published research and projections are kept apart, and estimates about Mars are identified as such rather than presented as established human outcomes.

The application

AstroCare is the app this research is meant for. It shows an astronaut’s vital signs in real time, keeps track of scheduled medical tests and radiation exposure, compares the values with each person’s own pre-flight baseline and raises alerts when something needs attention. It runs on a phone, with a simplified version for the Apple Watch, and includes an AI assistant that the crew can use by chat or by voice.

Our team

Members of the project and their role.

TS
Tomas Serrano
Robotics engineering student
AP
Andrea Peveroni
Computer engineering student
FO
Fernando Ortega
Multimedia engineer
IR
Igor Romanicaa
Multimedia systems engineer
OZ
Oskar Zajac
PhD candidate in nursing
OG
Oscar García
Multimedia systems engineer
Research basis. This study is based on the supplied report “Human health in microgravity: NASA measurements and investigations (Apollo–ISS)” and the supplied six-month evolution charts, with cross-checks against NASA Human Research Program, OCHMO and NASA Technical Reports Server material.

Simulated astronaut report